Similar articles

• [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].

  Mori K, Hattori N, Sobue G. Mori K, et al. Nihon Naika Gakkai Zasshi. 2002 Aug 10;91(8):2443-57. Nihon Naika Gakkai Zasshi. 2002. PMID: 12373856 Review. Japanese. No abstract available.
• Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.

  Furiya Y, Hirano M, Kusunoki S, Ueda M, Sugie K, Nishiwaki T, Ueno S. Furiya Y, et al. Muscle Nerve. 2008 Dec;38(6):1630-3. doi: 10.1002/mus.21131. Muscle Nerve. 2008. PMID: 19016534
• Guillain-Barre syndrome in children.

  Tabarki-Melaiki B. Tabarki-Melaiki B. Neurosciences (Riyadh). 2011 Apr;16(2):174-5. Neurosciences (Riyadh). 2011. PMID: 21427674 No abstract available.
• [Guillain-Barré syndrome].

  Koga M, Yuki N. Koga M, et al. Ryoikibetsu Shokogun Shirizu. 2000;(31):35-8. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269101 Review. Japanese. No abstract available.
• [Dysimmune neuropathies: current diagnosis and therapy].

  Léger JM, Larue S, Dashi F. Léger JM, et al. Rev Prat. 2008 Nov 15;58(17):1887-9, 1892-4. Rev Prat. 2008. PMID: 19157204 French.